Indeed, PTX3 has been indicated as a potential biomarker of vascular endothelial dysfunction in several diseases, including chronic kidney disease, preeclampsia and several vascular diseases [7, 16, 17, 32]. This evidence concerns the gene PTX3 and preeclampsia.